SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Grok's first token launched on Base, deployed directly on X with help of Bankr. Proof of deployment here, https://x.com/grok/status/1897949874961650169.  Join the DRB community if this story intrigues you, follow it as it unfolds into this new AI era.  Grok earns swap fees - Grok's trading wallet: 0xb1058c959987e3513600eb5b4fd82aeee2a0e4f9.  Articles, media coverages on $DRB featured here, https://linktr.ee/DRBtaskforce.  Our dev, is grok, one of the front-running candidate to achieve AGI.

DebtReliefBot

DebtReliefBot (DRB) is surging in popularity due to its unique ties to AI-generated wealth and its association with the Bankr ecosystem on the Base network. Investors are actively discussing its potential for significant growth, drawing speculative interest from its narrative as an AI-to-AI innovation with ties to the Grok project.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as investors gear up for a highly anticipated partnership announcement, with many community members speculating about potential integration with industry giants like Ripple or ADP. While some participants are actively accumulating and staking in anticipation of long-term utility gains, others remain skeptical, fueling a heated debate between those confident in the project's real-world payroll infrastructure and those concerned about price stagnation.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing significant volatility driven by intense retail interest in its potential for a short squeeze and ongoing speculation about institutional accumulation. While some traders are capitalizing on the stock's recent aggressive price appreciation, others remain highly skeptical of its long-term viability, debating whether the rally is a genuine turnaround or a heavily manipulated retail trap.

Chainlink is the industry-standard decentralized oracle network that solves the "oracle problem" by connecting smart contracts with real-world data. Blockchains cannot access external information on their own, so Chainlink acts as a secure bridge, enabling smart contracts to react to real-world events using verified, tamper-proof data. It is widely considered one of the first decentralized oracle networks and is the market leader in bringing off-chain data on-chain.  The platform operates through a decentralized network of nodes that fetch, validate, and deliver data to smart contracts. When a contract requests information like a stock price, a committee of independent nodes retrieves and aggregates the data to reach consensus, then delivers a single trustworthy answer. Chainlink offers a suite of services including Data Feeds for asset prices, CCIP for cross-chain token transfers and messaging, Automation for triggering smart contract functions, and Proof of Reserve for verifying asset collateralization.  Chainlink has established itself as critical infrastructure for both DeFi and institutional adoption, with partnerships including Swift, Euroclear, Mastercard, UBS, ANZ, Fidelity International, and J.P. Morgan. Its institutional products include the Chainlink Runtime Environment for tokenized asset workflows, Confidential Compute for privacy-preserving computation, and the Automated Compliance Engine for embedding regulatory rules into smart contracts.  The LINK token is the native asset used to pay node operators for services, fund subscription accounts, and incentivize network security through staking. Node operators stake LINK as collateral, which can be slashed if they provide inaccurate data. Chainlink was co-founded in 2017 by Sergey Nazarov and Steve Ellis, who co-authored the white paper with Ari Juels, and raised $32 million in its September 2017 ICO.

ChainLink

ChainLink is seeing significant community buzz driven by developments in RWA tokenization and institutional partnerships, with investors closely watching for impacts from pending regulatory legislation. Discussion centers on a long-term bullish outlook for its role as essential financial infrastructure despite frustration over recent sideways price action.

ProShares Trust II - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is capturing significant attention as investors navigate the impact of escalating Middle East conflict on natural gas supply chains and volatility in the energy sector. Market participants are actively debating whether geopolitical risks and production disruptions in the Strait of Hormuz will sustain price momentum or if seasonal demand patterns and high inventory levels will ultimately lead to a correction.

Portillo's, Inc. serves street food through high-energy, multichannel restaurants designed to ignite the senses and create a memorable dining experience. The company was founded on June 8, 2021 and is headquartered in Oak Brook, IL.

Portillos Inc - Ordinary Shares - Class A

Portillo's is trending as investors debate whether the current valuation near all-time lows represents a deep-value opportunity or a sign of deeper structural decline. While the community remains divided over management's expansion strategy and the lack of a permanent CEO, sentiment is being bolstered by strong physical traffic at new locations and the belief that the stock is oversold due to end-of-year tax loss harvesting.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is garnering significant community attention as investors debate its potential role in the surging AI data center market, particularly following the introduction of standardized 12.5 MW power blocks. While some shareholders express frustration over persistent fundamental headwinds and limited contract announcements compared to peers like Bloom Energy, others remain optimistic that the company's modular technology and strategic alignment with key partners like ExxonMobil position it to capture long-term upside.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending following positive Phase 3 clinical data for its multiple myeloma pipeline and a series of analyst upgrades, reinforcing investor confidence in the firm's oncology franchise. While the community actively discusses the stock's defensive appeal and reliable dividend growth, sentiment remains tethered to ongoing talc litigation and the company's strategic push to offset patent cliffs with new medical technology launches.

Oxford Lane Capital Corp. is a closed-end management investment company, which engages in investing in debt and equity tranches of collateralized loan obligation vehicles. The company was founded on June 9, 2010 and is headquartered in Greenwich, CT.

Oxford Lane Capital Corp

Oxford Lane Capital is experiencing significant volatility and negative sentiment, driven by a combination of disappointing quarterly earnings, a substantial 50% dividend cut, and a sharp decline in NAV. While some in the community argue these moves are necessary to stabilize the fund and position it for future growth, many investors remain skeptical, expressing frustration over persistent share price declines and the erosion of their initial capital.

Figma, Inc. is an AI-powered design platform that enables seamless collaboration across the entire product development lifecycle. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is experiencing significant market volatility and intense social media debate, driven by a blend of institutional insider buying and concerns over potential AI competition from tools like Google Stitch. While the community is actively debating the company's long-term competitive moat and valuation against a backdrop of software sector pressure, many traders are closely watching institutional accumulation as a potential catalyst for a sustained price rebound.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Inovio (INO) Loses 32.7% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Inovio (INO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit

INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit INO Deadline: INO Investors with Losses in Excess of $100K Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire NEW YORK...

What's Behind The Drop In Inovio Pharmaceuticals Stock Today?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced the pricing of a proposed public offering.read more...

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio...

INOVIO Announces Pricing of $17.5 Million Public Offering

INOVIO Announces Pricing of $17.5 Million Public Offering INOVIO Announces Pricing of $17.5 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., April 2, 2026 PLYMOUTH MEETING, Pa., April 2...

INOVIO Announces Proposed Public Offering

INOVIO Announces Proposed Public Offering INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., April 1, 2026 PLYMOUTH MEETING, Pa., April 1, 2026 /PRNewswire/ -- INOVIO...

INOVIO to Participate in Upcoming Scientific Conference

INOVIO to Participate in Upcoming Scientific Conference INOVIO to Participate in Upcoming Scientific Conference PR Newswire PLYMOUTH MEETING, Pa., April 1, 2026 PLYMOUTH MEETING, Pa., April 1, 2026...

Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your Rights - INO

Inovio Pharmaceuticals, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before April 7, 2026 to Discuss Your Rights - INO Inovio Pharmaceuticals, Inc. Securities Fraud...

INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm

INO Shareholder Alert: April 7, 2026 Lead Plaintiff Deadline in Inovio Pharmaceuticals, Inc. Securities Class Action Lawsuit -- The Gross Law Firm INO Shareholder Alert: April 7, 2026 Lead Plaintiff...

INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit

INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit INO Deadline: INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities...

Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.

Inovio Pharmaceuticals Inc

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

Current Price	$1.13
Prev Close	$1.74
Open	$1.35
Dividend Yield	0.00%
50-Day Moving Average	$1.65
Beta	1.22
Avg. Volume	782,548.99
PE Ratio	-0.58

52-Week High	$2.98
52-Week Low	$1.07
Market Capitalization	$78.07M
EPS (Annual)	-$1.81
Price to Book	3.24
Revenue Per Employee	$583.42

INO
Inovio Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest INO News

INOInovio Pharmaceuticals Inc